HER2 expression status in diverse cancers: review of results from 37,992 patients von Yan, Min, Schwaederle, Maria, Arguello, David, Millis, Sherri Z., Gatalica, Zoran, Kurzrock, Razelle

Volltext

Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma von Bridge, Julia A., Sumegi, Janos, Druta, Mihaela, Bui, Marilyn M., Henderson-Jackson, Evita, Linos, Konstantinos, Baker, Michael, Walko, Christine M., Millis, Sherri, Brohl, Andrew S.

Volltext

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma von Gounder, Mrinal M., Agaram, Narasimhan P., Trabucco, Sally E., Robinson, Victoria, Ferraro, Richard A., Millis, Sherri Z., Krishnan, Anita, Lee, Jessica, Attia, Steven, Abida, Wassim, Drilon, Alexander, Chi, Ping, Angelo, Sandra P. D’, Dickson, Mark A., Keohan, Mary Lou, Kelly, Ciara M., Agulnik, Mark, Chawla, Sant P., Choy, Edwin, Chugh, Rashmi, Meyer, Christian F., Myer, Parvathi A., Moore, Jessica L., Okimoto, Ross A., Pollock, Raphael E., Ravi, Vinod, Singh, Arun S., Somaiah, Neeta, Wagner, Andrew J., Healey, John H., Frampton, Garrett M., Venstrom, Jeffrey M., Ross, Jeffrey S., Ladanyi, Marc, Singer, Samuel, Brennan, Murray F., Schwartz, Gary K., Lazar, Alexander J., Thomas, David M., Maki, Robert G., Tap, William D., Ali, Siraj M., Jin, Dexter X.

Volltext

Phosphatidylinositol 3‐kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities von Millis, Sherri Z., Jardim, Denis L., Albacker, Lee, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Kurzrock, Razelle

Volltext

BRCA1/2 Functional Loss Defines a Targetable Subset in Leiomyosarcoma von Seligson, Nathan D., Kautto, Esko A., Passen, Edward N., Stets, Colin, Toland, Amanda E., Millis, Sherri Z., Meyer, Christian F., Hays, John L., Chen, James L.

Volltext

Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma von Ang, Celina, Klempner, Samuel J, Ali, Siraj M, Madison, Russell, Ross, Jeffrey S, Severson, Eric A, Fabrizio, David, Goodman, Aaron, Kurzrock, Razelle, Suh, James, Millis, Sherri Z

Volltext

Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets von Movva, Sujana, Wen, Wenhsiang, Chen, Wangjuh, Millis, Sherri Z, Gatalica, Zoran, Reddy, Sandeep, von Mehren, Margaret, Van Tine, Brian A

Volltext

Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications von Millis, Sherri Z, Gatalica, Zoran, Winkler, Josiah, Vranic, Semir, Kimbrough, Jeffery, Reddy, Sandeep, O'Shaughnessy, Joyce A

Volltext

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1 von Gatalica, Zoran, Bilalovic, Nurija, Palazzo, Juan P, Bender, Ryan P, Swensen, Jeffrey, Millis, Sherri Z, Vranic, Semir, Von Hoff, Daniel, Arceci, Robert J

Volltext

Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach von Kim, Kevin B., Soroceanu, Liliana, de Semir, David, Millis, Sherri Z., Ross, Jeffrey, Vosoughi, Elham, Dar, Altaf A., Nosrati, Mehdi, Desprez, Pierre-Yves, Ice, Ryan, Chen, Michelle, Chetal, Kashish, Bhattacharjee, Anukana, Moretto, John, Leong, Stanley P., Singer, Mark I., Parrett, Brian M., Minor, David R., McAllister, Sean, Miller, James R., Salomonis, Nathan, Kashani-Sabet, Mohammed

Volltext

Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors von Jardim, Denis L F, Millis, Sherri Z, Ross, Jeffrey S, Lippman, Scott, Ali, Siraj M, Kurzrock, Razelle

Volltext

Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma von Bill, Kate Lynn J., Seligson, Nathan D., Hays, John L., Awasthi, Achal, Demoret, Bryce, Stets, Colin W., Duggan, Megan C., Bupathi, Manojkumar, Brock, Guy N., Millis, Sherri Z., Shakya, Reena, Timmers, Cynthia D., Wakely, Paul E., Pollock, Raphael E., Chen, James L.

Volltext

Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability von Bieg-Bourne, Cheyennedra C, Millis, Sherri Z, Piccioni, David E, Fanta, Paul T, Goldberg, Michael E, Chmielecki, Juliann, Parker, Barbara A, Kurzrock, Razelle

Volltext

Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions von Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle

Volltext

PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation von Joseph, Richard W, Millis, Sherri Z, Carballido, Estrella M, Bryant, David, Gatalica, Zoran, Reddy, Sandeep, Bryce, Alan H, Vogelzang, Nicholas J, Stanton, Melissa L, Castle, Erik P, Ho, Thai H

Volltext

Recurrent secondary genomic alterations in desmoplastic small round cell tumors von Chow, Warren A, Yee, Jiing-Kuan, Tsark, Walter, Wu, Xiwei, Qin, Hanjun, Guan, Min, Ross, Jeffrey S, Ali, Siraj M, Millis, Sherri Z

Volltext

Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials von Friedlander, Michael L, Russell, Kenneth, Millis, Sherri, Gatalica, Zoran, Bender, Ryan, Voss, Andreas

Volltext

Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases von Gatalica, Zoran, Millis, Sherri Z, Vranic, Semir, Bender, Ryan, Basu, Gargi D, Voss, Andreas, Von Hoff, Daniel D

Volltext

Gene partners of the EWSR1 fusion may represent molecularly distinct entities von Walker, Victoria, Jin, Dexter X., Millis, Sherri Z., Nasri, Elham, Corao-Uribe, Diana A., Tan, Aik Choon, Fridley, Brooke L., Chen, James L., Seligson, Nathan D.

Volltext

Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics von Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle

Volltext